“The 30-year fixed-rate mortgage remained flat this week,” said Sam Khater, Freddie Mac’s Chief Economist. “Over the summer, rates have come down and purchase applications are outpacing 2024, though a ...

In 2022, BTCS issued the first ever Bitcoin dividend as a Nasdaq issuer. EST created a framework to make this possible in a compliant, cost-effective, and efficient manner. BTCS is now issuing an ...

Dubai, UAE, August 21st, 2025, ChainwireBybit, the world’s second-largest cryptocurrency exchange by trading volume, ...

TORONTO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Clairvest Group Inc. (TSX: CVG) (“CVG”) announced a material adverse regulatory development with respect to Head Digital Works (the “Company”), a leading ...

As Avidlove marks this 10-year anniversary, Avidlove invites you to celebrate with us—by discovering the pieces designed to light up your life’s most meaningful moments. Whether you're looking for ...

TORONTO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- OMERS generated a net investment return of 2.2%, a gain of $3.1 billion, for the period of January 1 to June 30, 2025. This result brings the cumulative ...

Back to school season is the perfect time to upgrade your tracking game. And with 20% off sitewide, there’s never been a ...

Neutral Curtains , a pioneer in sustainable interior solutions, today debuted the Cove Collection , an innovative series of ...

The Sales Center is located at 528 Exploration Circle in Liberty Hill, Texas. For more information on Santa Rita Ranch and Toll Brothers communities throughout Austin, call (833) 405-8655 or visit ...

Driven by a commitment to pure, non-toxic materials, the Cove Collection utilizes a high-purity cotton construction to deliver an environment of unparalleled safety and comfort. By harnessing cotton’s ...

RYE, N.Y., Aug. 21, 2025 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & Wellness Rx Trust (NYSE:GRX) (the “Fund”) declared a $0.17 per share cash distribution which will be ...

Based on promising early evidence of efficacy in the treatment of non-small cell lung cancer (NSCLC), the Company was granted an End of Phase 2 meeting with the United States Food and Drug ...